Man Group PLC Crispr Therapeutics Ag Transaction History

Man Group PLC

$35.6 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$60.67 - $89.12 $7.64 Million - $11.2 Million	-125,885 Reduced 53.37%	109,991 $7.5 Million
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $2.24 Million - $4.18 Million	57,941 Added 32.56%	235,876 $14.8 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $2.1 Million - $2.73 Million	46,224 Added 35.1%	177,935 $8.08 Million
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $5.73 Million - $8.93 Million	131,711 New	131,711 $7.39 Million
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $252,895 - $431,905	-5,850 Reduced 9.48%	55,840 $3.39 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $3.28 Million - $4.89 Million	61,690 New	61,690 $3.87 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $1.74 Million - $2.76 Million	-24,759 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $2.73 Million - $3.88 Million	24,759 New	24,759 $2.77 Million
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $182,923 - $293,668	-1,814 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $2.55 Million - $4.83 Million	-23,012 Reduced 92.69%	1,814 $221,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $1.05 Million - $2.27 Million	13,120 Added 112.08%	24,826 $3.8 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $5.78 Million - $7.41 Million	-73,581 Reduced 86.27%	11,706 $979,000
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $2.89 Million - $5.71 Million	75,081 Added 735.66%	85,287 $6.27 Million
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $1.22 Million - $2.26 Million	-36,188 Reduced 78.0%	10,206 $433,000
Q4 2019 Feb 18, 2020	BUY	$36.68 - $73.13 $1.7 Million - $3.39 Million	46,394 New	46,394 $2.83 Million
Q2 2019 Aug 14, 2019	SELL	$35.45 - $48.2 $1.81 Million - $2.46 Million	-50,959 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.02 - $40.87 $1.43 Million - $2.08 Million	50,959 New	50,959 $1.82 Million
Q4 2018 Feb 14, 2019	SELL	$22.73 - $42.34 $200,501 - $373,481	-8,821 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $391,211 - $579,627	8,821 New	8,821 $392,000

Others Institutions Holding CRSP

# of Institutions

483

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

8.97M
Shares

$469 Million
3.09% of portfolio
Capital International Investors Los Angeles, CA

8.74M
Shares

$457 Million
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.81M
Shares

$199 Million
0.09% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$145 Million
0.0% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.75M
Shares

$143 Million
0.07% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.07B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account